Mum given less than a year to live after taking Mounjaro jab scare leads to diagnosis
Dawn Clegg, 51, started experiencing the pain in late March this year after using the injections, which aided her diabetes management.
However, a series of X-rays at the hospital revealed shadows on her lungs, kidneys, and breast, leading to a diagnosis of a soft-tissue cancer known as sarcoma.
She was informed that the tumours on her breast and kidney were benign, but the one on her lungs was a sarcoma, accounting for merely one per cent of all cancers.
Read more: LEGO school essentials include water bottle so 'perfect' all family members own
With over 100 known sarcomas, doctors have yet to pinpoint Dawn's specific type, leaving her without a viable treatment option.
Her devastated spouse, Arron Clegg, also 51, is now planning a 'living wake' in November to honour his wife, who has been given less than a year to live due to Britain's rarest cancer.
Arron shared: "She went to Lancaster Hospital A&E at the end of March with chest pains, which she thought were a side effect of Mounjaro, which she was taking to help with her diabetes.
"X-rays showed shadows on the lung, kidney and breast.
"We were devastated on hearing news of cancer in 3 areas - there is no cure and she is now terminal.
"The wake will mean she can spend quality time with friends and family whilst still alive rather than after the funeral that way she can see how much people care about her."
Dawn had been using Mounjaro weight loss injections to manage her diabetes but started experiencing chest tightness, which she initially thought was a side effect.
In late March, Dawn sought answers for her chest discomfort at Lancaster Hospital A&E.
She underwent several X-rays that detected shadows on her lungs, breasts, and kidney.
However, the following day, Dawn was "called back" to the hospital where they disclosed that the shadows were malignant.
Further tests indicated that the breast cancer was benign and the kidney issue was minor.
Yet, she received the "devastating" diagnosis that the lung cancer was sarcoma.
Sarcoma is an uncommon cancer that forms in the body's connective tissues, such as bone, cartilage, tendons, fat, and muscle.
Arron shared: "The doctors don't even know what type of sarcoma it is four months later.
"Sarcoma accounts for 1% of known cancers and with over 100 sarcomas, pinpointing the correct treatment is incredibly challenging.
"She is now terminal and there is a high chance she won't make her 52nd birthday next year."
Dawn commenced chemotherapy at Clatterbridge in Liverpool, but Arron has been informed "there is more chance of it not working then slowing it down".
Following Dawn's grim prognosis, Arron is keen to arrange a 'living wake' – a celebration of her life with loved ones while she can still be part of it.
Arron is planning to gather roughly 100 of his wife's nearest and dearest for one last cherished evening together.
Arron shared: "Dawn means the world to me.
"We went to school together and started dating after we found each other years later and have been married nearly 10 years.
"Dawn is an amazing person; not very patient and yet with this illness she has surprised us both with her patience whilst they tried to find a treatment.
"She is the best person I ever knew and the wake will mean the world to her."
In due course, Dawn's farewell will continue with a service at Lancaster and Morecambe Crematorium, where she will be peacefully laid to rest beside her beloved daughter Isobel, who tragically passed away during childbirth.
Dawn, who works as a receptionist at Bay Medical Group, is also a proud mother to George, her 19 year old son who is currently pursuing film production at university in Leeds.
Arron has since initiated a crowdfunding effort to cover the expenses of the wake and funeral, scheduled for November 29, 2025.
Supporters can contribute to Arron's fundraising online here: https://www.gofundme.com/f/to-the-best-person-i-ever-knew-my-wife-dawn-clegg.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Breakup Blues Are Fuelling a Surge in Hair Transplant Travel, Says Clinic Prime
British Men Are Quietly Booking Hair Transplants After Breakups — And Flying to Turkey to Do It LONDON, July 21, 2025 /PRNewswire/ -- Breakups hurt — but for a growing number of British men, the fix isn't a pint with the lads or a new tattoo. It's a fresh hairline. And they're flying to Turkey to get it done. Clinic Prime , a UK-focused cosmetic medical provider based in Istanbul, reports a sharp uptick in bookings from recently single men. These patients aren't just chasing aesthetics — they're seeking closure, control, and confidence. "We've heard it dozens of times now: 'I just split up, and it's time to do something for me,'" said Sam, UK Representative for Clinic Prime. "It's a quiet form of self-reinvention." Why Post-Breakup Hair Transplants? Relationship endings often trigger a desire for change — new routines, new goals, new hairlines. Clinic Prime says the pattern is clear: most of these men had never seriously considered a procedure until their breakup. Now, a growing number are opting for hair transplant Turkey services that offer medical precision at a fraction of the UK cost. Studies show that post-breakup life changes are common, especially among men in their 30s and 40s. For many, hair restoration is not just about regrowth — it's a way to reclaim identity and project renewed self-worth. Confidence, after all, starts at the top. Why British Patients Choose Clinic Prime With rising demand for expert-led, affordable cosmetic treatment abroad, Clinic Prime has become a top destination for UK patients looking for trustworthy results without the middlemen. Key advantages include: Free video consultations with English-speaking medical staff Fixed, transparent pricing — no upselling or hidden fees All-inclusive packages covering airport transfers, 5-star hotel stays, and aftercare FUE and DHI techniques with natural-looking, long-term results Excellent patient reviews across platforms like Trustpilot Clinic Prime's surgeons have performed thousands of successful procedures, operating to international clinical standards. Each treatment plan is fully bespoke, ensuring the final result matches the patient's goals, hair type, and face shape. A Fresh Start — Without the Premium Price Tag A comparable procedure on Harley Street or in Mayfair can cost upwards of £8,000. In Turkey, that same level of surgical expertise — often with the same equipment and global certifications — starts at less than half the price. "It's not about cutting corners," Sam explains. "It's about cutting through the fluff." And while cosmetic tourism can be risky, Clinic Prime offers something different: no brokers, no upsells, no vague WhatsApp chats — just direct, patient-first care with clinical transparency. Ready for a New Chapter? For many men, a breakup is the push they didn't know they needed. "They leave with a new look, but more importantly, with a renewed sense of who they are," says Sam. To book a consultation or explore treatment packages, visit . Media Contact: Clinic Prime Media Teampress@ Clinic Prime is a leading medical aesthetics and hair transplant clinic based in Istanbul, Turkey. Known for its advanced technology, personalised care, and internationally accredited doctors, Clinic Prime provides high-quality treatments to patients from across the UK and beyond. Photo - - View original content to download multimedia: SOURCE Clinic Prime Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Medscape
an hour ago
- Medscape
Prevention, Screening, Treatment: Impact on Cancer Deaths
This transcript has been edited for clarity. Hello. I'm Dr Maurie Markman from City of Hope, and I'd like to discuss a very important study. I think many of you may have heard about this, but it's important to emphasize what these investigators reported in terms of the impact of what we are doing in the cancer world today and, in my opinion, what the focus needs to be on in the future. The paper I'm referring to is "Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020," published in JAMA Oncology . This was a very interesting effort; there was modeling done, and assumptions were made, in order to do what these investigators did. But this is, I think, very high-quality and reasonable data science. The paper outlines the assumptions made in coming to the conclusions reached by these investigators. They looked at breast, cervix, colorectal, lung, and prostate cancers — obviously, major cancers — and specifically looked at what the impact has been over the past 45 years of these three different strategies in averting deaths: prevention, screening, and actual treatment. The bottom line, as reported by these investigators, is that over this 45-year period, 5.94 million deaths have been averted in these five cancers combined, due to the efforts of countless numbers of individuals, researchers, clinicians, public health officials, government regulators, etc. It's an incredible and an enormously positive contribution to society and to individual patient health. They note, and this is a powerful message, that 8 of the 10 deaths, 80%, that had been averted were due to efforts in cancer prevention and screening. It may come as a surprise to some, but not to all, because of our often very intense focus and money spent on treatments for established and advanced cancers over the past decades. There's no intent either in this paper or by me to denigrate — in any way, shape, or form — the enormous efforts that have been made in treatment. But if you look at the question of deaths averted, the vast majority have come from prevention and screening efforts. And clearly, there's cost involved in these efforts, but far less than that associated with development of treatments. They're even more specific in this paper: Screening, according to these investigators, has been responsible for essentially all reduction in cervix cancer, which we certainly know from the enormous contributions of the Pap smear screening and now HPV screening: 25% of breast cancer deaths were averted due to screening; 56% from prostate cancer; 79% of deaths from colorectal cancer; and, of course, from lung cancer, 98% of the impacts on cancer deaths has resulted from a reduction in smoking. So, overall a tremendous impact, a positive impact. So many individuals and organizations avert deaths, but it's critical to remember the role of prevention and screening. And as we move forward to the future, as we look at the epidemic we have of obesity in this country and the concern about the risk of alcohol on the risk for cancer, it is important to remember the critical role to the present but also for the future of prevention and screening. Thank you for your attention.
Yahoo
2 hours ago
- Yahoo
Mother and daughter found dead months after 999 call ‘missed opportunity'
A 999 call made by a mother who was later found dead along with her 'entirely dependent' daughter led to no ambulance being sent despite the call handler being given their address and postcode, an inquest has heard. Nottingham Coroner's Court was told Alphonsine Djiako Leuga, 47, suffered from sickle cell anaemia and died from pneumonia, while her 18-year-old daughter Loraine Choulla had learning difficulties and Down's syndrome and relied on her mother for food and hydration. A inquest into the deaths, expected to last for five days, began on Monday with assistant coroner Amanda Bewley hearing that Ms Leuga called 999 three months before her body was found, telling a call hander she was cold and could not move. The hearing was told that during the call, made shortly after 1pm on February 2 last year, Ms Leuga groaned, requested an ambulance and said 'I need help to my daughter' and 'I'm in the bed, I feel cold and can't move' before cutting off the line. She also gave details of her address in Hartley Road, Radford, Nottingham, where her body and that of her daughter were found on May 21 last year. Giving evidence to the inquest, East Midlands Ambulance Service's head of patient safety, Susan Jevons said the call handler, an emergency medical adviser, should have referred the call to the control room despatch officers. Ms Jevons said attempts had been made to call Ms Leuga back, but she told the inquest: 'The call should have been left for an ambulance to attend once we had got the address, which we had. 'The ambulance didn't go to the address because the emergency medical adviser, thinking it was an abandoned call, closed the call down. 'So it wasn't visible to anybody within the emergency operations centre.' The coroner told Ms Jevons she would have to consider the possibility that sending an ambulance to the address 'might have been the difference between life or death' for Loraine. The inquest was told that Ms Leuga was admitted to hospital for a blood transfusion in late January last year as she was critically ill with very low iron levels, and was given a 'pragmatic' discharge linked to her daughter's care needs. The coroner asked Ms Jevons whether, if she found at the end of the inquest that Loraine had died after her mother, there had been a 'missed opportunity' in relation to the teenager's death. Ms Jevons responded: 'Yes, there was a missed opportunity for an ambulance to attend Alphonsine when she requested one.' Earlier, pathologist Dr Stuart Hamilton told the hearing by video-link that the mother and daughter were both likely to have been dead for 'weeks to months' before they were found, rather than for days or hours. Dr Hamilton said his initial cause of death following a post-mortem examination on Ms Leuga was pneumonia of uncertain cause, while her daughter's cause of death could not be established. Answering questions from the coroner, the pathologist said he could not rule out that Ms Leuga had died on the day of the 999 call. The body of Loraine, who the inquest was told was 'entirely dependent on her mother to meet her hydration and nutritional needs', showed no evidence of any third party involvement. Dr Hamilton said of the teenager: 'Unfortunately, based on the post-mortem examination and additional tests alone, it is my view that the cause of death is classed as unascertained – that is, I am not able to give a cause of death on the balance of probabilities.' Asked to comment on the possibility that Loraine's death may have been because of dehydration or malnutrition, Dr Hamilton answered: 'There is nothing in my findings that say any of that is incorrect.' Loraine was more likely to have died from dehydration than malnutrition, the witness said, if it was accepted that she 'wasn't able to make the decision to drink water' because of her difficulties. The inquest continues.
